Moran John E, Ash Stephen R
Satellite Healthcare, Mountain View, CA 94041, USA.
Semin Dial. 2008 Sep-Oct;21(5):490-2. doi: 10.1111/j.1525-139X.2008.00466.x. Epub 2008 Aug 29.
There is wide variation in the use of solutions to "lock" or fill tunneled central venous catheters for dialysis. Some centers use undiluted heparin concentrations ranging from 1000 to 10,000 U/ml and other centers place from 1000 to 10,000 U per lumen. Based on available evidence, it appears that heparin 1000 U/ml, or 4% sodium citrate are suitable choices for lock solution to maintain patency of tunneled central venous catheters for dialysis. Risks from systemic anticoagulation are lower with heparin 1000 U/ml and 4% sodium citrate, compared with higher concentrations of heparin (5000 and 10,000 U/ml). The need for use of tissue plasminogen activator for maintaining catheter patency is increased by using heparin lock at 1000 U/ml, vs. higher concentrations. Higher concentrations of heparin lock should be reserved for patients who have evidence of catheter occlusion or thrombosis when heparin is used at 1000 U/ml. Similar choices for lock solution are sensible for acute hemodialysis catheters. When heparin is used for catheter lock, the injected volume should not exceed the internal volume of the catheter.
在用于“封管”或充盈透析用带隧道中心静脉导管的溶液使用方面存在很大差异。一些中心使用浓度范围为1000至10000 U/ml的未稀释肝素,而其他中心则在每个管腔内放置1000至10000 U肝素。根据现有证据,肝素1000 U/ml或4%柠檬酸钠似乎是维持透析用带隧道中心静脉导管通畅的封管溶液的合适选择。与较高浓度的肝素(5000和10000 U/ml)相比,肝素1000 U/ml和4%柠檬酸钠引起全身抗凝的风险较低。与较高浓度相比,使用1000 U/ml肝素封管会增加使用组织纤溶酶原激活剂来维持导管通畅的必要性。当使用1000 U/ml肝素时,较高浓度的肝素封管应保留给有导管堵塞或血栓形成证据的患者。对于急性血液透析导管,封管溶液的类似选择是合理的。当使用肝素进行导管封管时,注入的体积不应超过导管的内部容积。